ABSTRACT
This study focused on assessing the language needs of English-speaking animal professionals in their interactions with Hispanic/Spanish-speaking animal caretakers. A survey was administered to a target audience of non-Spanish speaking and bilingual animal professionals to identify communication gaps while interacting with Hispanic/Spanish-speaking animal caretakers. The data was analyzed with descriptive and inferential statistics, including ordinal regression analyses to examine the impact of demographic variables on respondents' answer choices. The results showed that English-speaking professionals struggled with written and oral communication, which differed compared to bilingual professionals (p < 0.05). Additionally, responses of female professionals varied regarding the aspects of Spanish necessary for interacting with Hispanic/Spanish-speaking animal caretakers, as well as the topics likely to be addressed when agriculture professionals communicate with animal caretakers (p < 0.05). Communication difficulties in the oral medium for both oral receptive skills (listening) and oral productive skills (speaking) were reported as the major barriers that animal professionals need to overcome in their attempt to communicate with the Hispanic/Spanish-speaking workforce in farm settings. This emphasizes the need to address oral communication barriers, and to a lesser degree, the development of reading and writing skills. The topics: typical clinical signs of illness, euthanasia, treatment-drugs, and identification of sick or injured animals were identified as the most likely to be addressed during on-farm interactions. These findings indicate that there are gaps in communication that need to be overcome to improve communication with on-farm Hispanic/Spanish-speaking animal caretakers and consequently contribute to enhancing animal health, welfare, and production.
ABSTRACT
El aumento en la sobrevida de los recién nacidos prematuros, las características del cuidado neonatal y la escasez de programas para la prevención, detección y tratamiento de la retinopatía del prematuro provocan que esta enfermedad sea la principal causa de ceguera infantil prevenible en México. El advenimiento de agentes antiangiogénicos de uso oncológico, y su uso -no autorizado, aunque con buenos resultados- en el tratamiento de enfermedades vaso proliferativas en la retina del paciente adulto, así como la presencia de reportes anecdóticos en la literatura y series de casos con serias fallas metodológicas han sugerido su utilización en el tratamiento de la retinopatía del prematuro. Desafortunadamente, estos agentes, utilizados indiscriminadamente, presentan absorción sistémica y causan efectos secundarios en el organismo del paciente prematuro. Además, no existen estudios de seguimiento a largo plazo que garanticen la seguridad de su uso en esta población. El presente artículo describe la situación en nuestro país y advierte sobre los riesgos de estos medicamentos en la población de pacientes prematuros.
The increase in survival rates among preterm infants, characteristics of neonatal care for such infants and a lack of suitable programs for preventing, detecting and treating retinopathy of prematurity (ROP) are factors that have made this disease the main cause of preventable blindness among children in Mexico. The advent of antiangiogenic agents in cancer treatment and their off-label use with favorable results in the treatment of proliferative vessel disease of the retina among adult patients, as well as anecdotal reports in the literature and a series of cases showing serious methodological flaws, have prompted their use in the treatment of retinopathy of prematurity. Unfortunately, these agents used indiscriminately in our country have a systemic absorption and secondary effects on the preterm patient's body. There are no long-term monitoring studies that guarantee their safe use in this segment of the population. This article describes the situation in our country and warns of the risks posed by the use of this type of drug on the preterm infant population.
ABSTRACT
BACKGROUND: The "Early Treatment for Retinopathy of Prematurity Cooperative" reported a failure rate of 55.2% using laser in zone 1 for treatment of retinopathy of prematurity (ROP). We need to offer better alternatives for those patients. We undertook this study to evaluate the efficacy of combined laser-ranibizumab therapy for ROP with threshold-prethreshold and "plus disease" and to study development of the newborn. METHODS: This is a prospective, experimental, longitudinal and open study including newborns of either <32 weeks of gestation or with a birth weight <1500 g, with threshold-prethreshold retinopathy or "plus disease." The effect of treatment was analyzed and development of the newborn was determined. RESULTS: We studied 34 eyes of 17 patients. Age at birth was 29.9 ± 2.6 weeks. Birth weight was 1,120 ± 253 g. The statistics demonstrated an important relationship between severity of retinopathy and early birth age, along with a high probability of threshold-prethreshold disease at 29.4 weeks of age or 1204 g birth weight. The Bayley scale reported normal development in 23.5% of cases, global retardation in 23.5%, psychomotor retardation but normal mental behavior in 29.4%, and mental retardation but normal psychomotor development in 23.5%. We demonstrated regression of retinopathy in all cases. Persistence of vascular tortuosity was present in 17.6% of cases without vascular dilatation, and vitreous membrane development was demonstrated in 11.7% of patients. CONCLUSIONS: Laser-ranibizumab treatment has allowed a better control of retinopathy for threshold-prethreshold and "plus disease" in this group of patients.
Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Laser Coagulation , Retinopathy of Prematurity/therapy , Angiogenesis Inhibitors/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Combined Modality Therapy , Disease Progression , Female , Gestational Age , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Infant, Premature , Intellectual Disability/complications , Intravitreal Injections , Male , Postoperative Complications/epidemiology , Prospective Studies , Psychomotor Disorders/complications , Ranibizumab , Retinal Vessels/pathology , Retinopathy of Prematurity/complications , Retinopathy of Prematurity/drug therapy , Retinopathy of Prematurity/pathology , Retinopathy of Prematurity/surgery , Treatment Outcome , VasodilationABSTRACT
Pattern dystrophies are defined as a group of diseases genetically determined and characterized by pigment epithelium changes that are seen on fundus examination, such as various line and dot patterns. We present a review of these pathologies including a comparative table reporting the main characteristics as well as some representative figures of each one in order to facilitate diagnosis.
Subject(s)
Macular Degeneration/pathology , Retinal Pigment Epithelium , Humans , Macular Degeneration/classificationABSTRACT
Las distrofias en patrón son patologías de la retina genéticamente determinadas que se caracterizan por anormalidades en el epitelio pigmentario que se visualizan en el fondo de ojo conformando diversos patrones de puntos o líneas. Realizamos una revisión detallada de las diversas variedades de presentación y sus características más importantes, e incluimos una secuencia fotográfica de las más representativas.
Pattern dystrophies are defined as a group of diseases genetically determined and characterized by pigment epithelium changes that are seen on fundus examination, such as various line and dot patterns. We present a review of these pathologies including a comparative table reporting the main characteristics as well as some representative figures of each one in order to facilitate diagnosis.
Subject(s)
Humans , Macular Degeneration/pathology , Retinal Pigment Epithelium , Macular Degeneration/classificationABSTRACT
El objetivo principal del estudio fue conocer la eficacia de aceite de Copaiba en el tratamiento de Cervicitis; cuya muestra es no probalística intencional constituida por 10 mujeres en edad fértil seis con cervicitis aguda y cuatro con cervicitis crónica. El diseño de investigación fue cuasiexperimental de series cronológicas de un sólo grupo, se aplicó el estímulo en cinco sesiones con intervalo de una semana; cuya eficacia fue del 80 por ciento. Se evidencia que la recuperación de pacientes con cervicitis es a partir de la segunda sesión de tratamiento en 40 por ciento (> 50 por ciento) en cervicitis aguda; al 100 por ciento (> 50 por ciento) en la tercera sesión, en ambos tipos de cervicitis; obteniendose una recuperación total de paciente en la quinta sesión en 80 por ciento (seis casos aguda y dos casos crónica) y el 20 por ciento (dos casos de crónica) quedaron en la recuperación de > 50 por ciento comprobándose la hipotesis y concluyendo que el tratamiento de la cervicitis con el aceite copaiba fue eficaz en un 80 por ciento de los casos estudiados. Siendo la recomendación principal para obtener un resultado más óptimo de recuperación de cervicitis, brindar tratamiento en la cervicitis crónica con aceite copaiba por mayor tiempo de cinco semanas y previa al frotis del papanicolau.
The main objetive of the studio was to know the effectiveness of copaiba oil in the cervicitis treatment; whose sample it is not probabilistic intentional constituted for 10 women in fertile age: six with sharp cervicitis and four with chronic cervicitis. The investigation design was cuasi experimental of chronological series of one alone group. It was applied the stimulated in five sessions of interval of one week; whose effectiveness was of the 80 per cent. It is evidenced that the recovery of patient with cervicitis in 40 per cent ( 50 per cent being proven the hypothesis and concluding that the treatment of the cervicitis with copaiba oil was effective in a 80 per cent of the studied cases. Being but good of cervicitis recovery, to ofter treatment i the chronicle cervicitis with copaiba oil for more time of fifth weeks and previos to the smear of the papanicolau.
Subject(s)
Female , Humans , Adolescent , Adult , Uterine Cervicitis , Uterine Cervicitis/therapy , Fabaceae , Fertility , Women , Treatment Outcome , Oils/therapeutic use , Applied ResearchABSTRACT
Se informa de una recién nacida pretérmino de 33.5 semanas, con 12 días de vida extrauterina, quien al nacimiento presentó varias malformaciones características de la asociación VACTER: escoliosis dorsolumbar, displasia de vértebras lumbosacras, ausencia de ano y displasia renal, entre otras; además, al efectuar la autopsia, se encontró una masa pélvica que histológicamente correspondía a un teratoma maduro. La presencia de esta neoplasia en la asociación VACTER no ha sido descrita previamente
